New laser procedure shows promise for glaucoma patients

NCT ID NCT05654493

Completed Disease control Sponsor: Mayo Clinic Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study from the Mayo Clinic tested a laser procedure called MP-TSCPC in 65 glaucoma patients to see how well it lowers eye pressure. Researchers tracked patients for one year after the procedure, measuring changes in eye pressure, medication use, and vision. The goal was to evaluate if this laser treatment is a safe and effective option for managing glaucoma.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: MicroPulse Transscleral Laser Therapy (MP-TSCPC) using a revised P3 Delivery Device
What this could lead to: If successful, this laser procedure could offer a safe and effective way to lower eye pressure in glaucoma patients, potentially reducing the need for daily eye drops.
What could go wrong: This is a small, single-center observational study with no comparison group. The results may not apply to all glaucoma patients, and the procedure carries risks like inflammation or temporary vision changes.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for GLAUCOMA are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

glaucoma

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

GLAUCOMA

Contacts and locations

Locations

Mayo Clinic Florida

Jacksonville, Florida, 32224, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.